PI11375 5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one (CAS No.: 150322-38-6)

5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one (CAS No.: 150322-38-6) Description

This compound, with the chemical formula C18H18FNO2S and CAS 150322-38-6, is synthesised as a pharmaceutical intermediate in powder form. Its defined structure, featuring a cyclopropyl group and a fluorophenyl moiety, contributes to a controlled reactivity profile essential for precise modifications. The consistent behaviour of this intermediate supports its use in multi-step synthesis where reproducibility is vital.

5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one (CAS No.: 150322-38-6) Applications

Pharmaceutical Synthesis
   - Used as a reaction precursor in API pathways to achieve controlled reaction mechanisms by leveraging its predictable chemical reactivity.
   - Serves as a key intermediate to streamline synthetic routes, reducing variability in downstream product formation.

Research Applications
   - Applied in synthesis optimisation studies to analyse reaction efficiency and mechanism, facilitating improved process scalability by exploiting its consistent behaviour.
   - Frequently used for structure-activity relationship studies where controlled modifications are required for product development.

5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one (CAS No.: 150322-38-6) Packing

The compound is packaged in moisture-proof, foil-lined containers that reduce exposure to ambient moisture and prevent contamination. Sealed under inert conditions with batch-specific labelling, the packaging ensures stability during transport and storage. Options for customised packaging, including additional insulation or tamper-evident wraps, are available to meet various laboratory and manufacturing requirements.

Additional Information

Pharmaceutical intermediates like this compound play a critical role in drug synthesis. Their precise chemical characteristics allow for dependable multi-step reactions, which are essential in the development of active pharmaceutical ingredients. Analytical verification and stringent process controls ensure that these intermediates perform consistently under varied synthesis conditions.

Understanding the impact of molecular structure on reactivity supports enhanced process design and optimisation. Advanced analytical techniques provide detailed insights into the compound's behaviour, facilitating continuous improvements in synthesis protocols and overall efficiency in pharmaceutical manufacturing.